BioLife Solutions, Inc. Standard Product Warranty Accrual, Increase (Decrease) for Preexisting Warranties
BioLife Solutions, Inc. (BLFS) reported Standard Product Warranty Accrual, Increase (Decrease) for Preexisting Warranties of $1.60 million for the 12-month period ending 2022-12-31, per its 10-K filed 2024-02-29.
Discontinued › Notes › Product Warranties Disclosures
us-gaap:StandardProductWarrantyAccrualPreexistingIncreaseDecrease · last filed 2024-02-29
- BioLife Solutions, Inc. standard product warranty accrual, increase (decrease) for preexisting warranties for the quarter ending 2022-12-31 was $1.00M.
- BioLife Solutions, Inc. standard product warranty accrual, increase (decrease) for preexisting warranties for the quarter ending 2022-09-30 was $100.00K.
- BioLife Solutions, Inc. standard product warranty accrual, increase (decrease) for preexisting warranties for the quarter ending 2022-06-30 was -$25.00K.
- BioLife Solutions, Inc. standard product warranty accrual, increase (decrease) for preexisting warranties for the quarter ending 2022-03-31 was $525.00K.
- BioLife Solutions, Inc. standard product warranty accrual, increase (decrease) for preexisting warranties for fiscal 2022 was $1.60M, a 45.45% increase from fiscal 2021.
- BioLife Solutions, Inc. standard product warranty accrual, increase (decrease) for preexisting warranties for fiscal 2021 was $1.10M.
| Period end | Standard Product Warranty Accrual, Increase (Decrease) for Preexisting Warranties 3 month | Standard Product Warranty Accrual, Increase (Decrease) for Preexisting Warranties 6 month | Standard Product Warranty Accrual, Increase (Decrease) for Preexisting Warranties 9 month | Standard Product Warranty Accrual, Increase (Decrease) for Preexisting Warranties 12 month |
|---|---|---|---|---|
| 2022-12-31 | $1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $1.10M derived: sum of 2 quarters · filed 2024-02-29 | $1.07M derived: sum of 3 quarters · filed 2024-02-29 | $1.60M 10-K · filed 2024-02-29 |
| 2022-09-30 | $100.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $75.00K derived: sum of 2 quarters · filed 2023-11-09 | $600.00K 10-Q · filed 2023-11-09 | |
| 2022-06-30 | -$25.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $500.00K 10-Q · filed 2023-08-09 | ||
| 2022-03-31 | $525.00K 10-Q · filed 2023-05-11 | |||
| 2021-12-31 | $1.10M 10-K · filed 2024-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B |